Safety, Tolerability and PK of Multiple-ascending Doses of Emodepside
NCT03383614
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
24
Enrollment
OTHER
Sponsor class
Conditions
Filariasis
Interventions
DRUG:
LSF emodepside (BAY 44-4400) or matching placebo
Sponsor
Drugs for Neglected Diseases
Collaborators
[object Object]
[object Object]